Simplification, cost-reduction strategies and examples from the field Teri Roberts Diagnostics Advisor Médecins Sans Frontières, Access Campaign 7th.

Slides:



Advertisements
Similar presentations
Dr. Thaweesak Tirawatnapong Chula Medical Research Center (Chula MRC)
Advertisements

Results of a Pilot Point-of-Care (POC) HIV Testing Program using INSTI HIV in an Urban Sexual Health Clinic in Canada Presentation to: 2007 HIV Diagnostics.
Affordable Resistance Testing for Africa (ART-A)
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
MSF Experience on Use of HIV Viral Load testing in Myanmar.
The Current Pipeline for Point-of-Care Virologic Testing for HIV/AIDS Scaling up Virologic Diagnostic HIV Testing in Infants and Rationalizing Decentralization.
Technical and Operational Considerations for Scaling Up
Use of Dried Blood Spots (DBS) Specimens for Measuring HIV-1 Viral Load in Argentina M. Lorena Vázquez Inés Zapiola Ana Gun Silvia Gómez Alejandro Krolewiecki.
The South African Cryptococcal Screening Program: Program update XIX international AIDS Conference Washington United States 24 th July 2012 Dr. Samuel.
Viral Load Monitoring of ART: Feasibility & Affordability of Scale up IAS, Kuala Lumpur, 1 st July 2013 Presented by: Nalinikanta Rajkumar, CoNE.
Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more.
WHO Guidelines for treatment monitoring Nathan Ford Dept of HIV/AIDS World Health Organization.
Challenges in Scaling Up VL in Resource Limited Settings Collins Otieno Odhiambo KEMRI/CDC.
High incidence of HIV in young women despite high ART coverage and viral load suppression Results from a population-based survey in KwaZulu-Natal, South.
The UNITAID-funded MSF diagnostics project: Plans to incorporate the new WHO recommendations and how best practices will be shared with, and disseminated.
Preliminary findings of a routine PMTCT Option B+ programme in a rural district in Malawi Rebecca M. Coulborn 1, Laura Triviño Duran 1, Carol Metcalf 2,
Community models of ART delivery in Southern Africa MSF Regional experience E. Goemaere, Medecins Sans Frontieres IAS Washington, July 26 th 2012.
Global Strategy, Policy and Normative Guidance for POC Diagnostics Gottfried Hirnschall MD, MPH Department of HIV/AIDS, World Health Organization July.
Changes in population-level HIV RNA distribution one year after implementation of key components of an HIV ‘test and treat’ strategy in rural Uganda Vivek.
Effectiveness of Micronutrient-rich Lipid Nutrient Supplements in Delaying Clinical Progression of HIV in Malawian Adults Heidi Sandige, MD.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Diagnosis of HIV Infection in Children HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Charlie Masiku Deputy Medical Coordinator MSF HIV Project, Chiradzulu, Malawi Capetown 22nd September 2014 Early experience with implementation of SAMBA.
HCV PCR By Henrietta Orji July 31 st, 2010 Hepatitis C Virus by Polymerase Chain Reaction.
3 rd South African AIDS Conference, Durban 2007 Plugging the leaky cascade, Rome IAS, July 2011 Plugging the Leaky Cascade: Programmatic adjustments for.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Community-based Adherence Clubs improve outcomes for stable ART patients: Outcomes from Cape Town, South Africa Anna Grimsrud 1, Maia Lesosky 1,2, Cathy.
ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
Task-shifting of HIV care and ART initiation: Three year evaluation of a mixed-care provider model for ART delivery Megan McGuire 1, Jihane Ben-Farhat.
Challenges in adapting chronic HIV/TB services to high mobile populations in Southern Africa Eric Goemaere, MD Médecins Sans Frontières IAS Washington,
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Evaluation of two techniques for viral load monitoring on DBS ANRS project Phase I - Laboratory.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Phar. Nhat Mang/ Roche Vietnam
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Integrated Community HIV Testing Campaigns: Leveraging HIV infrastructure for non- communicable diseases July 23, 2012 Gabriel Chamie, Dalsone Kwarisiima,
Evaluating a novel semi-quantitative viral load test in the field: field trial for patient monitoring in Malawi and Uganda Dr. Suna Balkan MSF.
Attrition between TB / HIV testing and linkage to care in South Africa’s correctional facilities. 01 December 2015 Vincent Zishiri, Salome Charalambous,
BioMérieux’s commitment in the fight against HIV Michel Bonnier VP Public Health.
Using DBS for viral diagnosis in ressources limited setting Senegalese experiences.
Evaluation of SAMBA Viral Load point-of-care test operation by trained non-health workers in rural Health Centers, Chiradzulu District, Malawi Birgit.
Boston University Slideshow Title Goes Here Eliminating CD4 thresholds in South Africa will not lead to large increases in persons receiving ART without.
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
LOW HCV PREVALENCE AMONG HIV+ INDIVIDUALS IN SUB-SAHARAN AFRICA
Joseph Kibachio4, William Etienne1, Saar Baert5, Helen Bygrave5
Post natal integrated clubs as a way to improve retention in care of mother infant pairs in a primary care setting, Khayelitsha, South Africa. Aurélie.
Emphasis programmatic / civil society and lab must not act in silos – need to come together for effective scale up Programmatic and Laboratory Must Speak.
Implementation of routine HIV viral load monitoring A multisite cascade analysis Munyaradzi Dhodho1, Marthe Frieden1, Amir Shroufi2, Esther Wanjiru3, Sarah.
Amir Shroufi Medical Coordinator MSF South Africa
Durban, July 20th 2016 Ruggero Giuliani MSF - Mozambique
Gaps in the cascade of care in two high prevalence settings in Zimbabwe and Malawi Nolwenn Conan1, Cyrus Paye2, Erica Simons2, Abraham Mapfumo3, Tsitsi.
Implementation of routine HIV viral load monitoring A multisite cascade analysis Munyaradzi Dhodho1, Marthe Frieden1, Amir Shroufi2, Esther Wanjiru3, Sarah.
  Link with at IAS 2017 OPHID and partners are proud to be presenting 9 abstracts and co-hosting a Satellite Session sharing.
Evaluation of Alere q HIV-1/2 VL Plasma
Madisa Mine National Health Laboratory Gaborone, BOTSWANA
Utilizing research as an opportunity to strengthen
VL patient support: General education at different levels
The role of CD4 in patient monitoring Amsterdam July 2018
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Extended ART Initiation Criteria Can Be Implemented Successfully in Rural South Africa Sarah Jane Steele1, Gemma Arellano2, Tom Ellman3, Amir Shroufi1,
Effect of POC CD4 testing at HIV diagnosis on attrition prior to ART initiation among youth in Khayelitsha, South Africa Pre-treatment losses to care remains.
Towards the last 90% of the 90:90:90 strategy: A review of viral suppression rates in a HIV program in Central and Eastern Kenya Dr Moses Kitheka,
Implementation of routine HIV viral load monitoring A multisite cascade analysis Munyaradzi Dhodho1, Marthe Frieden1, Amir Shroufi2, Esther Wanjiru3, Sarah.
Joseph Perriëns World Health Organization Geneva
Multi-disease diagnostic integration
Stakeholder engagement and research utilization: Insights from Namibia
Performance of mPima for quantification of HIV Viral load for pregnant and post-partum woman in primary health care clinics in Mozambique Team: B. Meggi.
Title. Alternative technologies: performance and regulatory status Mexico City, Mexico July 2019.
Introduction and current status of viral load access
Presentation transcript:

Simplification, cost-reduction strategies and examples from the field Teri Roberts Diagnostics Advisor Médecins Sans Frontières, Access Campaign 7th International AIDS Conference 2 July 2013

Virological monitoring detects treatment failure earlier than clinico-immunological monitoring

How viral load testing fits into the package of care to ensure people stay undetectable Early treatment Routine viral load Adherence support Community- based & self- managed therapy Drop routine CD4 monitoring for virally suppressed ART treated PLWHA and rather use routine VL monitoring to trigger the need for CD4 testing (is CD4 over 200 cells/ul?)

Viremic patients can re-suppress following an adherence intervention

The importance of preserving first line, affordable, robust, one-pill-a-day regimens

Implementation is done in support of, and in collaboration with, the Ministries of Health and reference laboratories SAMBA CAVIDI BIOMERIEUX BIOCENTRIC

G. Patten et al. Poster TUPDD0106 (Oral abstract session: The point of point of care (Tuesday)) Youth and adolescents have been identified as a particularly vulnerable group, at greater risk of loss from both pre-ART and ART care. MSF supported clinic in Khayelitsha, Cape Town, South Africa: implemented POC CD4-testing at a clinic dedicated to youth aged 12 to 25 years. POC CD4 testing significantly improved assessment for ART eligibility, ensuring that most youth were made aware of their treatment needs on the day of HIV diagnosis. Does point-of-care (POC) CD4 testing reduce losses from care between HIV diagnosis, assessment for ART eligibility and ART initiation among HIV-positive youth in Khayelitsha, South Africa?

Group A (Before)Group B (After) HIV Testing Blood sample drawn for CD4 counting WHO Staging* ART preparation counselling sessions ART Initiation CD4 Result ART eligibility assessed Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 Visit 6 HIV Testing Blood sample drawn for CD4 counting WHO Staging ART preparation counselling session ART Initiation CD4 Result ART eligibility assessed Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 44% 50% 34 days 28 days P=0.6

Point-of-care versus laboratory-based tests for viral load testing Regional-level laboratory tests will use dried blood spot samples that can use finger or heel prick blood

Diagnostic accuracy of DBS using the COBAS Ampliprep/COBAS TaqMan HIV-1 v2.0 (CAP/CTM) NMRL, Harare, Zimbabwe in collaboration with MSF Sekesai Mtapuri-Zinyowera (WEPE610 - Poster Exhibition on Wednesday) 118 finger prick DBS, venous blood DBS and plasma specimens from ART patients attending two rural OI clinics in Buhera and Tsholotsho districts and one urban OI clinic in Harare  good sensitivity of DBS compared to HIV-1 RNA plasma but very low specificity, which translated in a higher rate of false positive results with DBS at lower VLs (<3.5log) COBAS ® AmpliPrep/COBAS ® TaqMan ® HIV-1 Test Dried Fluid Spot Procedure RUO Sample Collection ±70 μL of capillary and EDTA blood (air dry min. 3h) detach and transfer 1 spot (Ø 12 mm) 56 0 C, 10 min, 1000 rpm+1000 μL SPEX S-input tube Controls Fully automated nucleic acid extraction and amplification/detection Pre-extraction

Pooling methods, in combination with the use of fingerprick DBS as a sample type for VL testing, can importantly reduce costs while maintaining accuracy Efficiency expressed as cost savings: Example of Thyolo District – Population: 620,000 – HIV prevalence: 14,5% – # VL tests needed/year: 23,000 – Price per VL test: $24 Total cost/year = 23,000 x $24 = $552,000 – Efficiency at 1,000 cps/mL = 28,6% => $157,800 saved – Efficiency at 5,000 cps/mL = 51,4% => $283,700 saved Sample µL 100 µL Pool 500 µL Viral load testing 100 µL Sample µL Sample µL Sample µL Sample µL What to do with pooled results? 1. Pooled VL result no further testing 2. Pooled VL result > threshold => further testing MSF has previously validated the use of fingerprick DBS on the bioMerieux NucliSENS EasyQ HIV-1 platform, which is RNA-specific

Reports: IAS poster TUPDD0102 and Oral abstract session: The point of point of care (Tuesday) 2013